Ron Squarer Insider Trading
Get free email notifications about insider trading for Ron Squarer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ron Squarer. Ron Squarer is a CEO in ARRAY BIOPHARMA INC ($ARRY) and a Chief Commercial Officer in HOSPIRA INC ($HSP) and a SVP, Global Marketing in HOSPIRA INC ($HSP) and a Director in Retrophin, Inc. ($RTRX) and a Director in Deciphera Pharmaceuticals, Inc. ($DCPH).
Address: 275 NORTH FIELD DRIVE LAKE FOREST 60045 IL
Companies in which Ron Squarer is an Insider
ARRAY BIOPHARMA INC
Trading Symbol: ARRYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ron Squarer: CEO
Holdings: 442,190 shares
Current Value: $4,656,261
Latest Transaction: Jul 30 2019
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Deciphera Pharmaceuticals, Inc.
Trading Symbol: DCPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ron Squarer: Director
Holdings: 0 shares
Latest Transaction: Jan 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HOSPIRA INC
Trading Symbol: HSPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ron Squarer: Chief Commercial Officer, SVP, Global Marketing
Holdings: 5,594 shares
Latest Transaction: Feb 28 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Trading Symbol: RTRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ron Squarer: Director
Holdings: 14,875 shares
Current Value: $298,541
Latest Transaction: May 18 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ron Squarer
Sentiment: All, ARRY, DCPH, HSP, RTRX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2021 | RTRX | Travere Therapeuti ... | Squarer Ron | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
May 18 2021 | RTRX | Travere Therapeuti ... | Squarer Ron | Director | Grant | A | 0.00 | 3,000 | 0 | 14,875 | 11.9 K to 14.9 K (+25.26 %) |
Jan 20 2021 | DCPH | Deciphera Pharmace ... | Squarer Ron | Director | Option Exercise | A | 50.07 | 1,563 | 78,259 | 1,563 | |
Jul 17 2020 | DCPH | Deciphera Pharmace ... | Squarer Ron | Director | Option Exercise | A | 53.41 | 723 | 38,615 | 723 | |
Jun 12 2020 | DCPH | Deciphera Pharmace ... | Squarer Ron | Director | Option Exercise | A | 56.46 | 12,000 | 677,520 | 12,000 | |
May 19 2020 | RTRX | Retrophin, Inc. | Squarer Ron | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
May 19 2020 | RTRX | Retrophin, Inc. | Squarer Ron | Director | Grant | A | 0.00 | 3,000 | 0 | 11,875 | 8.9 K to 11.9 K (+33.80 %) |